Article info
Hepatology
Original article
Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations
- Correspondence to Angélique Gougelet Institut Cochin, INSERM U1016, CNRS UMR8104, Université Paris Descartes, 24, rue du Faubourg Saint Jacques, Paris 75014, France; Angelique.gougelet{at}inserm.fr
Citation
Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations
Publication history
- Received December 5, 2014
- Revised February 16, 2015
- Accepted February 18, 2015
- First published March 19, 2015.
Online issue publication
October 26, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/